Healthcare Ventures / Schering AG / Peplin / CSL / Vaxxas Pty Ltd / Xenome Ltd / Afandin / TenasiTech Pty Ltd / One Ventures / Millennium Pharmaceuticals / CM Capital / Uniseed Dr Peter Devine / ChemGenex Pharmaceuticals / UniQuest Pty Ltd / Merck and Co / AIBN Technology Translation Fund / Melbourne Ventures / Principal / Brandon Capital Partners / York Medical Technologies / Meditech Research / UniQuest Ltd / the Dow Chemical Company / Oncolin Dr Jim Aylward / /
Country
Australia / United Kingdom / United States / /
Currency
USD / / /
Event
Company Expansion / Funding / Business Partnership / Person Communication and Meetings / /
Facility
University of Queensland Business School / University of Queensland / The University of Queensland / Diabetes Institute / laboratory of AIBN / plant Euphorbia / AIBN building / Princeton University / $73m building / London University / Monash University / /
IndustryTerm
chemical resistance / pharmaceutical industry / early stage technology / biotechnology development / technology research / biotechnology consulting / finance team / energy / plastics / project applications / targeted financial support / life science investment/venture capital firms / biotechnology sector / training and experience in product / materials technology / venture capital / biotechnology / early stage products / potential solution / nascent technology / local and international biotechnology/pharmaceutical / level management / research / biotechnology industry / improvements to moulded or extruded products / venture capital investors / seed finance / /
Organization
Medical Research Commercialisation Fund / Baker IDI Heart and Diabetes Institute / Australian Academy of Technological Sciences and Engineering / Princeton University / Monash University / University of Queensland / Project Management Team / AIBNcubator Technology Translation Fund / Technology Translation Fund / National Health and Medical Research Council / University of Queensland Business School / AIBN mission / London University / AIBNcubator Management Team / Australian Research Council / IC / Investment Committee / Queensland government / UQ Business School / Australian Taxation Office / /
Person
Chris Nave / Jim Aylward / Dean Moss / Tim Kastelle / Ian Nisbet / Richard Marshall / Carrie Hilliyard / Carrie Hillyard / Darren Martin / Mark Kendall / Peter Devine / Petrina Gilmore / /
Position
technical advisor / Executive Director / chief executive officer and managing director / Head / ICD team representative / commercial advisor / senior business development executive / CEO / group leader / Professor / Professor / managing director / Executive / Principal Executive / Manager / External Relations and Advancement / co-founder / researcher / team member / Director of Commercialisation / Deputy Director / Director / Chair / Lecturer / CSIRO Principal Scientist / group leader / /
ProvinceOrState
Queensland / Victoria / New South Wales / Massachusetts / /
Region
South Wales / /
Technology
drug delivery / biotechnology / early stage technology / pdf / Nanopatch technology / /